HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children

Go back to HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
HCA HOLDINGS, Inc. (NYSE: HCA) Delayed: 371.87 --0 (-0%)
Previous Close $371.87    52 Week High $83.69 
Open $371.87    52 Week Low $60.07 
Day High $371.87    P/E 110.35 
Day Low $371.87    EPS $3.37 
Volume 91